{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:30:54Z","timestamp":1791919854989,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["R13-2003-013-04002-0"],"award-info":[{"award-number":["R13-2003-013-04002-0"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.clnu.2013.03.013","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T01:31:18Z","timestamp":1364261478000},"page":"156-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Wogonin ameliorates hyperglycemia and dyslipidemia via PPAR\u03b1 activation in db\/db mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Eun-Jung","family":"Bak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hui","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gye-Hyeong","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Heon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Jung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2013.03.013_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00125-011-2044-5","article-title":"Genetic predisposition to obesity leads to increased risk of type 2 diabetes","volume":"54","author":"Li","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2013.03.013_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/07435800701743810","article-title":"Pathogenesis of type 2 diabetes","volume":"32","author":"Stumvoll","year":"2007","journal-title":"Endocr Res"},{"key":"10.1016\/j.clnu.2013.03.013_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1096\/fj.00-0590","article-title":"Diseases of liporegulation: new perspective on obesity and related disorders","volume":"15","author":"Unger","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.clnu.2013.03.013_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","article-title":"Pathophysiology of insulin resistance in human disease","volume":"75","author":"Reaven","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clnu.2013.03.013_bib5","doi-asserted-by":"crossref","first-page":"679137","DOI":"10.1155\/2008\/679137","article-title":"Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders","volume":"2008","author":"Cho","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.clnu.2013.03.013_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrendo.2010.89","article-title":"PPARalpha: an emerging therapeutic target in diabetic microvascular damage","volume":"6","author":"Hiukka","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnu.2013.03.013_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2013.03.013_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1172\/JCI27955","article-title":"PPAR delta: a dagger in the heart of the metabolic syndrome","volume":"116","author":"Barish","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2013.03.013_bib9","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/endo.139.6.6049","article-title":"Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development","volume":"139","author":"Braissant","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.clnu.2013.03.013_bib10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/diabetes.52.7.1770","article-title":"Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis","volume":"52","author":"Kim","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2013.03.013_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.clnu.2013.03.013_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01072597","article-title":"Clofibrate therapy and gallstone induction","volume":"23","author":"Bateson","year":"1978","journal-title":"Am J Dig Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.clnu.2013.03.013_bib13","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/dmrr.252","article-title":"Differentiating members of the thiazolidinedione class: a focus on safety","volume":"18","author":"Lebovitz","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clnu.2013.03.013_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.diabet.2012.06.003","article-title":"Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis","volume":"38","author":"Colmers","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.clnu.2013.03.013_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1527-3458.2005.tb00266.x","article-title":"Therapeutic potential of wogonin: a naturally occurring flavonoid","volume":"11","author":"Tai","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.clnu.2013.03.013_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ptr.3013","article-title":"Wogonin inhibits osteoclast formation induced by lipopolysaccharide","volume":"24","author":"Jang","year":"2010","journal-title":"Phytother Res"},{"key":"10.1016\/j.clnu.2013.03.013_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.23064","article-title":"Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes","volume":"50","author":"Henkel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2013.03.013_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2006.02.045","article-title":"Effects of flavonoids extracted from Scutellaria baicalensis Georgi on hemin-nitrite-H2O2 induced liver injury","volume":"536","author":"Zhao","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clnu.2013.03.013_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jep.2009.04.031","article-title":"Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogs","volume":"124","author":"Peng","year":"2009","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.clnu.2013.03.013_bib20","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1016\/S0021-9258(19)85559-X","article-title":"Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes","volume":"255","author":"Student","year":"1980","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clnu.2013.03.013_bib21","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","article-title":"ADD1\/SREBP1 activates PPARgamma through the production of endogenous ligand","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnu.2013.03.013_bib22","first-page":"527","article-title":"Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice","volume":"140","author":"Takikawa","year":"2010","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.clnu.2013.03.013_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jnutbio.2010.08.014","article-title":"Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages","volume":"22","author":"Chen","year":"2011","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.clnu.2013.03.013_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jep.2012.04.034","article-title":"Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes","volume":"142","author":"Ho","year":"2012","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.clnu.2013.03.013_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.15.3.318","article-title":"Pathogenesis of NIDDM. A balanced overview","volume":"15","author":"DeFronzo","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2013.03.013_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2004.03.011","article-title":"Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha","volume":"220","author":"Kim","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clnu.2013.03.013_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/857142","article-title":"Protection from metabolic dysregulation, obesity, and atherosclerosis by citrus flavonoids: activation of hepatic PGC1alpha-mediated fatty acid oxidation","volume":"2012","author":"Mulvihill","year":"2012","journal-title":"PPAR Res"},{"key":"10.1016\/j.clnu.2013.03.013_bib28","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.clnu.2013.03.013_bib29","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.2337\/diabetes.54.12.3358","article-title":"Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination","volume":"54","author":"Tsuchida","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2013.03.013_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.ATV.0000256469.06782.d5","article-title":"Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level","volume":"27","author":"Hiuge","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clnu.2013.03.013_bib31","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2013.03.013_bib32","first-page":"CD002966","article-title":"Metformin monotherapy for type 2 diabetes mellitus","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2013.03.013_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2013.03.013_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2005.06.016","article-title":"Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase","volume":"518","author":"Huypens","year":"2005","journal-title":"Eur J Pharmacol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561413000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561413000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:50:42Z","timestamp":1759366242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561413000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0261561413000915"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2013.03.013","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wogonin ameliorates hyperglycemia and dyslipidemia via PPAR\u03b1 activation in db\/db mice","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2013.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}